Mendel Scott — SEC insider filings

SEC reporting owner CIK 1515051. 32 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2020-08-14 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
GenMark Diagnostics, Inc. (GNMK)President & CEO, Director13—8 legs · 231,672 sh · $3,390,29419
Akoya Biosciences, Inc. (AKYA)Director82 legs · 28,500 sh · $211,860—11
Quanterix Corp (QTRX)Director7——11
Quantum-Si Inc (QSI)Director4——4

Insider filings — Mendel Scott

FiledFormIssuerReported transactionsSource
2026-10-024Quanterix Corp (QTRX)Grant/award (A): 4,398 @ $3.41EDGAR
2026-07-094Quanterix Corp (QTRX)Option exercise (M): 8,073 · Option exercise (M): 8,073 (derivative) @ $0EDGAR
2026-07-024Quanterix Corp (QTRX)Grant/award (A): 3,456 @ $4.34EDGAR
2026-05-204Quantum-Si Inc (QSI)Grant/award (A): 251,185 (derivative) @ $0EDGAR
2026-04-074Quanterix Corp (QTRX)Grant/award (A): 4,310 @ $0EDGAR
2026-01-064Quanterix Corp (QTRX)Grant/award (A): 23,372 @ $0 · Grant/award (A): 1,944 @ $0EDGAR
2025-10-034Quanterix Corp (QTRX)Grant/award (A): 2,084 @ $5.54EDGAR
2025-07-104Quanterix Corp (QTRX)Grant/award (A): 4,189 · Grant/award (A): 24,464 @ $0 · Grant/award (A): 50,758 (derivative) @ $0EDGAR
2025-07-104Akoya Biosciences, Inc. (AKYA)Other (J): 28,500 · Other (J): 35,562 (derivative) @ $0 · Other (J): 30,549 (derivative) @ $0 · Other (J): 56,322 (derivative) @ $0 · Other (J): 44,959 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0EDGAR
2025-05-214Quantum-Si Inc (QSI)Grant/award (A): 126,095 (derivative) @ $0EDGAR
2024-10-044Akoya Biosciences, Inc. (AKYA)Grant/award (A): 44,959 (derivative) @ $0EDGAR
2024-06-054Akoya Biosciences, Inc. (AKYA)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-174Quantum-Si Inc (QSI)Grant/award (A): 113,281 (derivative) @ $0EDGAR
2023-06-124Akoya Biosciences, Inc. (AKYA)Purchase (P): 20,000 @ $5EDGAR
2023-06-054Akoya Biosciences, Inc. (AKYA)Grant/award (A): 56,322 (derivative) @ $0EDGAR
2023-05-164Quantum-Si Inc (QSI)Grant/award (A): 141,843 @ $0EDGAR
2022-06-034Akoya Biosciences, Inc. (AKYA)Grant/award (A): 30,549 (derivative) @ $0EDGAR
2021-11-194Akoya Biosciences, Inc. (AKYA)Purchase (P): 8,500 @ $13.16EDGAR
2021-06-154Akoya Biosciences, Inc. (AKYA)Grant/award (A): 35,562 (derivative) @ $0EDGAR
2021-04-224GenMark Diagnostics, Inc. (GNMK)Code (U): 507,198 @ $24.05 · Code (U): 115,491 @ $24.05 · Disposition to issuer (D): 28,332 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 53,382 (derivative) · Disposition to issuer (D): 84,002 (derivative) · +1 moreEDGAR
2021-03-014GenMark Diagnostics, Inc. (GNMK)Tax withholding (F): 41,834 @ $0EDGAR
2021-02-254GenMark Diagnostics, Inc. (GNMK)Tax withholding (F): 3,254 @ $0EDGAR
2021-02-244GenMark Diagnostics, Inc. (GNMK)Tax withholding (F): 1,860 @ $0EDGAR
2021-02-224GenMark Diagnostics, Inc. (GNMK)Tax withholding (F): 3,952 @ $0 · Grant/award (A): 80,070 @ $0 · Grant/award (A): 26,691 (derivative) @ $0EDGAR
2021-01-254GenMark Diagnostics, Inc. (GNMK)Sale (S): 64,975 @ $14.23EDGAR
2021-01-214GenMark Diagnostics, Inc. (GNMK)Sale (S): 50,000 @ $14.54 · Option exercise (M): 50,074 @ $0 · Option exercise (M): 46,098 @ $0 · Option exercise (M): 50,000 @ $0 · Option exercise (M): 50,074 (derivative) @ $0 · Option exercise (M): 46,098 (derivative) @ $0 · +1 moreEDGAR
2020-11-254GenMark Diagnostics, Inc. (GNMK)Sale (S): 5,190 @ $13.17EDGAR
2020-11-204GenMark Diagnostics, Inc. (GNMK)Sale (S): 3,987 @ $13.85EDGAR
2020-08-284GenMark Diagnostics, Inc. (GNMK)Sale (S): 50,000 @ $15.02EDGAR
2020-08-264GenMark Diagnostics, Inc. (GNMK)Sale (S): 4,532 @ $14.14EDGAR
2020-08-244GenMark Diagnostics, Inc. (GNMK)Sale (S): 2,988 @ $15.41EDGAR
2020-08-144GenMark Diagnostics, Inc. (GNMK)Sale (S): 50,000 @ $15.08EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1515051 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs